Finance

Lists
Q2 2026 earnings • released • EPS beat +9.09% • Revenue beat +3.21%
See results
PNTG:NASDAQ
Pennant Group Inc
$39.00
-0.15%
(-0.060) 1D
$39.00
0.00% (0.00)
After hours
Closed: Aug 7, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for PNTG...
Open
$38.68
High
$39.15
Low
$38.29
Mkt. cap
1.36B
Avg. vol.
336.54K
Volume
180.54K
P/E ratio
45.63
52-wk high
$42.69
52-wk low
$22.26
EPS
$0.85
Beta
1.26
Shares outstanding
34.93M
No. of employees
10K
Open
$38.68
High
$39.15
Low
$38.29
Mkt. cap
1.36B
Avg. vol.
336.54K
Volume
180.54K
P/E ratio
45.63
52-wk high
$42.69
52-wk low
$22.26
EPS
$0.85
Beta
1.26
Shares outstanding
34.93M
No. of employees
10K
News stories
From sources across the web
About Pennant Group Inc
CEO-
Employees9.7K
Founded2019
Headquarters-
SectorHealth care provider
Websitepennantgroup.com
Analyst ratings
Based on 3 analysts giving stock ratings to PNTG in the past 3 months
Strong buy
Buy
3
Hold
0
Sell
0
12-month forecast
Based on 3 Wall Street analysts offering 12 month price targets for PNTG in the last 3 months.
Highest
Current $39.00
$48.00 (+23.08%)
Average
$46.50 (+19.23%)
Lowest
$45.00 (+15.38%)
Analyst
Recommendation
Action
Price target
Projected
Date
David S Macdonald
Truist Financial
Buy
Reiterated
$48.00
+23.1%
08/07/2026
Jared Haase
William Blair
Buy
Reiterated
-
-
08/05/2026
Stephen Baxter
Wells Fargo
Buy
Maintained
$45.00
+15.4%
07/13/2026
Michael Wiederhorn
Oppenheimer
Buy
Maintained
$40.00
+2.6%
05/08/2026
Ben Hendrix
RBC Capital
Buy
Maintained
$42.00
+7.7%
05/07/2026
Unknown Analyst
Stephens
Buy
Maintained
$37.00
-5.1%
04/02/2026
Last report
Aug 6, 2026
Fiscal period
Q2 2026
EPS / Est. (USD)
$0.36 / $0.33
+9.09%beat
Revenue / Est. (USD)
297.98M / 288.71M
+3.21%beat
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
229.04M
289.32M
285.36M
297.98M
Cost of goods sold
182.88M
234.20M
230.35M
241.38M
Cost of revenue
182.88M
234.20M
230.35M
241.38M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
33.91M
34.69M
35.50M
35.04M
Operating expense
35.98M
37.05M
38.12M
38.15M
Total operating expenses
218.85M
271.25M
268.47M
279.53M
Operating income
10.19M
18.07M
16.89M
18.45M
Other non operating income
182.00K
54.00K
-146.00K
626.00K
EBT including unusual items
9.40M
14.27M
14.09M
14.83M
EBT excluding unusual items
9.35M
14.87M
13.68M
16.10M
Income tax expense
2.52M
3.90M
3.79M
3.94M
Effective tax rate
26.78%
27.30%
26.93%
26.53%
Other operating expenses
-
-
-
-
Net income
6.08M
8.64M
8.52M
9.08M
Net profit margin
2.65%
2.99%
2.99%
3.05%
Earnings per share
0.30
0.34
0.32
0.36
Interest and investment income
-
-
-
-
Interest expense
-1.02M
-3.25M
-3.07M
-3.35M
Net interest expenses
-1.02M
-3.25M
-3.07M
-3.35M
Depreciation and amortization charges
2.06M
2.36M
2.62M
3.11M
EBITDA
12.25M
20.43M
19.51M
21.56M
Gain or loss from assets sale
-51.00K
100.00K
-
9.00K
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Create a portfolio
Create a task
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps